@viewbill48
Active 2 years, 5 months ago
However, virtually any affected person addressed with a good defense checkpoint inhibitor is a threat regarding immune-related adverse activities (irAEs). Gate chemical pneumonitis (CIP) can be a unusual yet potentially extreme lung toxic body of immunotherapy. Because the image characteristics as well as symptoms are not distinct, detecting CIP […] View
Giles Demant’s Docs
| Has attachment | Title | Created | Last Edited | Tags |
|---|---|---|---|---|
|
There are no docs for this view. |
